FBTAX
Price
$29.12
Change
+$0.36 (+1.25%)
Updated
Dec 20 closing price
LYFCX
Price
$12.31
Change
+$0.03 (+0.24%)
Updated
Dec 20 closing price
Ad is loading...

FBTAX vs LYFCX

Header iconFBTAX vs LYFCX Comparison
Open Charts FBTAX vs LYFCXBanner chart's image
Fidelity Advisor Biotechnology A
Price$29.12
Change+$0.36 (+1.25%)
VolumeN/A
CapitalizationN/A
AlphaCentric Life Sciences & Hlthcare C
Price$12.31
Change+$0.03 (+0.24%)
VolumeN/A
CapitalizationN/A
FBTAX vs LYFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LYFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a StrongBuy and LYFCX is a StrongSell.

FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.74B vs. LYFCX (53.2M). FBTAX pays higher dividends than LYFCX: FBTAX (1.02) vs LYFCX (0.00). FBTAX was incepted earlier than LYFCX: FBTAX (24 years) vs LYFCX (5 years). LYFCX is a more actively managed with annual turnover of: 142.00 vs. FBTAX (78.00). FBTAX has a lower initial minimum investment than LYFCX: FBTAX (0) vs LYFCX (2500). FBTAX annual gain was more profitable for investors over the last year : 15.19 vs. LYFCX (2.60). LYFCX return over 5 years is better than : 21.56 vs. FBTAX (6.68).
FBTAXLYFCXFBTAX / LYFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years5 years-
Gain YTD6.511-1.227-531%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets1.74B53.2M3,269%
Annual Yield % from dividends1.020.00-
Returns for 1 year15.192.60583%
Returns for 3 years8.06-5.00-161%
Returns for 5 years6.6821.5631%
Returns for 10 years24.57N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LNNGY54.391.41
+2.66%
Li Ning Co., Ltd.
HSQVY10.34-0.06
-0.58%
Husqvarna AB
ALYAF1.14-0.01
-0.87%
Alithya Group Inc.
NPSNY46.08-0.74
-1.58%
Naspers Ltd.
CYTOF0.12-0.18
-60.07%
Altamira Therapeutics Ltd